Profile data is unavailable for this security.
About the company
Alibaba Health Information Technology Ltd is an investment holding company mainly engaged in the provision of Internet solutions for the medical and pharmaceutical industry, and is Alibaba Group’s healthcare flagship platform. The Company is mainly involved in the development of pharmaceutical and healthcare product and service sales business, the operation of pharmaceutical e-commerce platform and consumer healthcare services platform, the development of tracking and digital health business and Internet healthcare business using technologies such as cloud computing and big data.
- Revenue in HKD (TTM)37.53bn
- Net income in HKD2.19bn
- Incorporated1998
- Employees1.36k
- LocationAlibaba Health Information Technology Ltd26/F,Tower One, Times Square, 1 Matheson Stre Hong KongHKG
- Phone+852 25839333
- Fax+852 22155200
- Websitehttps://www.alihealth.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dashenlin Pharmaceutical Group Co Ltd | 30.35bn | 1.29bn | 25.48bn | 43.53k | 19.76 | 3.12 | -- | 0.8395 | 1.00 | 1.00 | 23.86 | 6.35 | 1.03 | 4.28 | 22.02 | 616,415.10 | 4.72 | 5.62 | 10.67 | 11.14 | 33.97 | 36.48 | 4.57 | 5.00 | 0.6584 | 12.56 | 0.4131 | 51.24 | 8.01 | 18.92 | -21.58 | 5.42 | 24.10 | 16.46 |
| Yifeng Pharmacy Chain Co Ltd | 27.29bn | 1.86bn | 32.78bn | 40.02k | 17.97 | 2.59 | -- | 1.20 | 1.33 | 1.33 | 19.54 | 9.22 | 0.9057 | 3.51 | 15.33 | 602,957.60 | 6.66 | 6.75 | 12.23 | 12.46 | 39.73 | 38.98 | 7.36 | 6.83 | 1.01 | 67.62 | 0.2836 | 28.44 | 6.53 | 18.55 | 8.26 | 22.96 | 8.50 | 45.96 |
| MatsukiyoCocokara & Co | 54.40bn | 2.77bn | 51.68bn | 12.75k | 18.17 | 1.91 | 13.13 | 0.9499 | 140.11 | 140.11 | 2,747.74 | 1,330.72 | 1.51 | 4.62 | 15.17 | 86,210,780.00 | 7.76 | 6.89 | 10.29 | 8.96 | 35.25 | 34.03 | 5.13 | 4.74 | 1.26 | -- | 0.0028 | 29.83 | 3.82 | 12.44 | 4.45 | 15.87 | 18.34 | 13.53 |
| Alibaba Hlth Infrmtn Tchnlgy Ltd | 37.53bn | 2.19bn | 83.46bn | 1.36k | 38.09 | 4.17 | 37.02 | 2.22 | 0.1355 | 0.1355 | 2.32 | 1.24 | 1.52 | 13.46 | 31.11 | 27,511,880.00 | 8.86 | 3.19 | 11.64 | 4.20 | 24.48 | 22.21 | 5.84 | 2.43 | 2.34 | -- | 0.0043 | 0.00 | 13.22 | 26.10 | 62.14 | -- | 6.95 | -- |
| JD Health International Inc | 73.99bn | 5.37bn | 166.32bn | 4.57k | 30.78 | 2.52 | 29.59 | 2.25 | 1.69 | 1.69 | 23.29 | 20.59 | 0.8938 | 7.55 | 306.77 | 20,759,590.00 | 6.47 | -4.51 | 8.49 | -5.66 | 23.81 | 22.63 | 7.24 | -5.58 | 2.55 | -- | 0.0074 | -- | 8.65 | 39.93 | 94.31 | -- | 52.13 | -- |
Data as of Mar 04 2026. Currency figures normalised to Alibaba Health Information Technology Ltd's reporting currency: Hong Kong Dollar HKD
12.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 18 Feb 2026 | 690.71m | 4.27% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 302.88m | 1.87% |
| Krane Funds Advisors LLCas of 05 Feb 2026 | 286.08m | 1.77% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 226.68m | 1.40% |
| CSOP Asset Management Ltd.as of 05 Feb 2026 | 170.10m | 1.05% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 122.15m | 0.76% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 85.68m | 0.53% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 76.91m | 0.48% |
| Hang Seng Investment Management Ltd.as of 06 Feb 2026 | 71.38m | 0.44% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 58.39m | 0.36% |
More ▼
Data from 30 Jun 2025 - 09 Feb 2026Source: FactSet Research Systems Inc.
